Back to Agenda
Session 1, Part 4: Panel Discussion About Facilitated Regulatory Pathways & Good Regulatory Practice
Session Chair(s)
Paul Dearden
Senior Director, Global Regulatory Policy
Biogen, United Kingdom
Speaker(s)
Donia Al Bastaki
Ministry of Health, Drug and Food Control, Kuwait
Head of Registration Department, Pharmaceutical & Herbal Medicines Registration
Inas Chehimi
Novartis Pharma Services AG, United Arab Emirates
Head RA Middle East & North Africa
Bandar Al Hammad, MPharm
Saudi Food and Drug Authority (SFDA), Saudi Arabia
Chief Pharmacist, Regulatory Affairs Department
Stuart Russel Walker, PhD
Centre for Innovation In Regulatory Science (CIRS), United Kingdom
Professor and Consultant
Rasha Ziada
Egyptian Ministry of Health and Population, Egypt
Chairperson of the Central Adminstration of Pharmaceutical Affairs (CAPA)
Ghadeer Al-Sheikh Salem
Jordan Food and Drug Administration, Jordan
Head, Originator and Biological Drugs Division, Registration Department
Hajed M.H Hashan
Gulf Health Council, Saudi Arabia
Deputy of General Director
Have an account?